Method for detecting and quantifying adenovirus

Details for Australian Patent Application No. 2001235626 (hide)

Owner Aventis Pharma S.A. Institut Gustave Roussy

Inventors Gautier, Eric; Saulnier, Patrick; Vidaud, Michel

Agent Davies Collison Cave

Pub. Number AU-B-2001235626

PCT Pub. Number WO01/59163

Priority 00 01554 08.02.00 FR; 60227912 28.08.00 US

Filing date 7 February 2001

Wipo publication date 20 August 2001

Acceptance publication date 19 October 2006

International Classifications

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

19 October 2006 Application Accepted

  Published as AU-B-2001235626

15 February 2007 Standard Patent Sealed

27 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001235627-METHOD AND SYSTEM FOR GENERATING VIRTUAL AND COORDINATED MOVEMENTS BY SEQUENCING VIEWPOINTS

2001235625-Partners of PTB1 domain of FE65, preparation and uses